Schonfeld Strategic Advisors’s Cano Health, Inc. CANO Stock Holding History

Schonfeld Strategic Advisors’s Portfolio CANO Stock Details CANO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-270	Closed	-$37K	–	2851
2022 Q4	$37K	Sell	270 -8,636	-97%	-$2.92M	﹤0.01%	2283
2022 Q3	$7.72M	Buy	+8,906	New	+$5.58M	0.06%	390
2022 Q2	–	Sell	-184	Closed	-$117K	–	3184
2022 Q1	$117K	Sell	184 -3,173	-95%	-$2M	﹤0.01%	2187
2021 Q4	$2.99M	Buy	3,357 +1,891	+129%	+$1.99M	0.03%	595
2021 Q3	$1.86M	Buy	+1,466	New	+$1.78M	0.02%	741
2021 Q2	–	Sell	-1,640	Closed	-$2.17M	–	2427
2021 Q1	$2.17M	Buy	1,640 +265	+19%	+$375K	0.03%	640
2020 Q4	$1.84M	Buy	+1,375	New	+$1.57M	0.02%	617

Other funds holding CANO

DCP

Diameter Capital Partners New York $1.24B AUM 137.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return

NewEdge Wealth Pittsburgh, Pennsylvania $10B AUM 30.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

EHI

Eagle Health Investments Greenwich, Connecticut $603M AUM 111.06% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Schonfeld Strategic Advisors's CANO Position: Q1 2023 in Review

Schonfeld Strategic Advisors sold out of Cano Health, Inc. (CANO) in Q1 2023, closing a stake of 270 shares — an estimated $37K sold.

Schonfeld Strategic Advisors first reported a position in CANO in Q4 2020 and held it in 7 quarters. The position peaked at $7.72M in Q3 2022. 163 funds tracked by Wall St. Rank hold CANO as of Q1 2023.

Schonfeld Strategic Advisors reported no remaining Cano Health, Inc. position as of Q1 2023 after selling out during the quarter.
Schonfeld Strategic Advisors sold 270 Cano Health, Inc. shares in Q1 2023, an estimated $37K.
Schonfeld Strategic Advisors first reported a position in Cano Health, Inc. in Q4 2020 and held it in 7 quarters.
Schonfeld Strategic Advisors's Cano Health, Inc. position peaked at $7.72M in Q3 2022.
163 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q1 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2023, filed 15 May 2023.